Machine learning: new discoveries and challenges for life sciences

Machine learning originally sat on the high-tech side of the fence. Now, it has migrated into the life sciences realm of research.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

In-house counsel

In-house counsel rethink patent filing strategies as costs mount

3 November 2026 With budgets under pressure, counsel from Pfizer, ALX Oncology and BioMarin share how they are reassessing portfolios, trimming costs and prioritising key markets at LSPN Fall.

Careers

Fenwick hires NY partner to advise on regulatory matters

2 November 2026 New partner joins from Goodwin, where he was a life sciences partner, bringing experience in healthcare transactions, and regulatory and strategic counselling, among other areas.

Regulation & Industry

UK unveils £1bn sector investment push after recent setbacks

30 October 2026 With its goal of becoming a global life sciences leader still some way off, the UK is betting on new investment, AI and regulatory changes to help close the gap, according to the government’s autumn budget.

More features

Beyond the primary patent: How pharma can build competitive barriers

The ‘Triple Point’ professional: Why patent success requires science, law, and technology

The UPC plugs another gap in its procedural rulebook

USPTO appoints new acting commissioner for patents

Pharmascience v Janssen: Canada court updates methods of medical treatment protection

Patent office fee increases: What applicants must know

IndiaMart v CDSCO: A test of intermediary liability

Arnold & Porter adds tech litigator in San Francisco

Machine learning: new discoveries and challenges for life sciences

More on this story

Editor's picks

Editor's picks

More features